Israeli Firm Nucleai Raises $33M For Its AI Pathology Platform
Nucleai’s vision is to bring spatial biology to the forefront of precision medicine and embed its platform in every clinical trial involving tissue.
March 22, 2022
Israeli AI Diagnostics Firm Ibex Detects Cancer Using Advanced Algorithms
Ibex Medical Analytics' AI-powered technology helps pathologists detect and grade cancer in biopsies.
July 30, 2020
Israeli Startup Nucleai Raises $6.5M For Its AI Precision Oncology System
Founded in 2017, Nucleai developed a platform that leverages tissue datasets to produce insights into cancer biology, increase clinical trial efficacy and improve patient care.
July 08, 2020
Israeli AI Diagnostics Firm Ibex To Roll Out Cancer Screening For NHS Patients In UK
Founded in 2014, Ibex develops clinical-grade, AI-based solutions that help pathologists detect and grade cancer in biopsies
June 30, 2020
